Pharmacogenomics || Public Health Genomics Knowledge Base (v1.2)

Public Health Genomics Knowledge Base (v1.2)

 Pharmacogenomics expanded expanded

Using Pharmacogenetics to Predict Cancer Prognosis, Response to Treatment, and Toxicity
J Cavallo, ASCO Post, October 25, 2016

Getting Pharmacogenomics Into the Clinic 
J Abbasi, JAMA, September 21, 2016

Pharmacogenomics and Global Precision Medicine in the Context of Adverse Drug Reactions: Top 10 Opportunities and Challenges for the Next Decade.
Alessandrini Marco et al. Omics : a journal of integrative biology 2016 Sep

More information on this topic

Last Updated: Oct 28, 2016

• Using Pharmacogenetics to Predict Cancer Prognosis, Response to Treatment, and Toxicity
  J Cavallo, ASCO Post, October 25, 2016
• EGFR mutation status of paired cerebrospinal fluid and plasma samples in EGFR mutant non-small cell lung cancer with leptomeningeal metastases.
  Zhao Jing, et al. Cancer chemotherapy and pharmacology 2016 10
• Methotrexate impact on radiographic progression in biologic-treated rheumatoid arthritis under clinical remission: A case report on monozygotic Caucasian twins.
  Soukup Tomas, et al. International journal of immunopathology and pharmacology 2016 10
• Seizure variables and their relationship to genotype and functional abilities in the CDKL5 disorder.
  Fehr Stephanie, et al. Neurology 2016 10
• Triple Therapy Improves Colorectal Cancer Response.
  Cancer discovery 2016 10
• A success story in pharmacogenomics: genetic ID card for SJS/TEN.
  Sukasem Chonlaphat et al. Pharmacogenomics 2016 Apr 17(5) 455-8
• Economic analysis of pharmacogenomic-guided clopidogrel treatment in Serbian patients with myocardial infarction undergoing primary percutaneous coronary intervention.
  Mitropoulou Christina et al. Pharmacogenomics 2016 Oct
• Effects of Using Personal Genotype Data on Student Learning and Attitudes in a Pharmacogenomics Course.
  Weitzel Kristin Wiisanen et al. American journal of pharmaceutical education 2016 Sep 80(7) 122
• Evaluation of popular drug information resources on clinically useful and actionable pharmacogenomic information.
  Chang Jennifer S et al. Journal of the Medical Library Association : JMLA 2016 Jan 104(1) 58-61
• Role of Cytochrome P450 2B6 Pharmacogenomics in Determining Efavirenz-Mediated Central Nervous System Toxicity, Treatment Outcomes, and Dosage Adjustments in Patients with Human Immunodeficiency Virus Infection.
  Vo Teresa T et al. Pharmacotherapy 2016 Oct
• Effects of Genetic and Non-genetic Factors on Total and Bioavailable 25(OH)D Responses to Vitamin D Supplementation.
  Yao Pang, et al. The Journal of clinical endocrinology and metabolism 2016 10 jc20162930
• Genetic polymorphisms of Wnt/?-catenin pathway genes are associated with the efficacy and toxicities of radiotherapy in patients with nasopharyngeal carcinoma.
  Yu Jingjing, et al. Oncotarget 2016 10
• Pharmacokinetic Profile and Palatability of Atomoxetine Oral Solution in Healthy Japanese Male Adults.
  Nakano Masako, et al. Clinical drug investigation 2016 11 (11) 903-911
• [Clinicopathologic Features and Prognostic Implications in 72 Cases ?with Lung Adenosquamous Carcinoma].
  Wu Xi, et al. Zhongguo fei ai za zhi = Chinese journal of lung cancer 2016 10 (10) 653-658
• [Driven Gene in Patients with Lung Squamous Cell Carcinoma: ?Analysis of Clinicopathologic Characteristics and Prognosis].
  Zhang Tongtong, et al. Zhongguo fei ai za zhi = Chinese journal of lung cancer 2016 10 (10) 648-652

• CDC Information (4)
• CDC-Authored Pub (3)

• Human (104)
• Pathogen (1)

• Human (12914)
• Pathogen (0)

• Human (77)
• Pathogen (0)

• Guidelines (2)
• Tier Table (2)
• Synthesis (38)

Relevant Resources

• Cancer Genomics and Epidemiology Navigator (CGEN)
• Genetics and Genomics Competencies Center (G2C2)
• NIH Genetic Testing Registry
• NIH MedGen Database
• Online Mendelian Inheritance in Man (OMIM)
• PharmGKB